PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,000,570 | -48.1% | 1,197,673 | -17.3% | 0.02% | -47.1% |
| Q2 2023 | $19,254,304 | -22.9% | 1,447,692 | -32.9% | 0.03% | -26.1% |
| Q1 2023 | $24,968,402 | +15.1% | 2,156,166 | -18.7% | 0.05% | -4.2% |
| Q4 2022 | $21,689,982 | +7.0% | 2,651,587 | -24.1% | 0.05% | +6.7% |
| Q3 2022 | $20,278,000 | +19.2% | 3,493,262 | -9.3% | 0.04% | +21.6% |
| Q2 2022 | $17,015,000 | -52.5% | 3,849,549 | -2.2% | 0.04% | -48.6% |
| Q1 2022 | $35,820,000 | -34.6% | 3,936,287 | +47.2% | 0.07% | -30.1% |
| Q4 2021 | $54,730,000 | -15.3% | 2,674,954 | +5.8% | 0.10% | -24.3% |
| Q3 2021 | $64,608,000 | -27.5% | 2,528,691 | -0.8% | 0.14% | -31.3% |
| Q2 2021 | $89,146,000 | +26.6% | 2,549,225 | +20.6% | 0.20% | +11.9% |
| Q1 2021 | $70,388,000 | +25.1% | 2,113,129 | -2.6% | 0.18% | +22.1% |
| Q4 2020 | $56,265,000 | – | 2,169,036 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |